vs
Orthofix Medical Inc.（OFIX）与Ranger Energy Services, Inc.（RNGR）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Ranger Energy Services, Inc.的1.5倍（$219.9M vs $142.2M），Ranger Energy Services, Inc.净利率更高（2.3% vs -1.0%，领先3.3%），Orthofix Medical Inc.同比增速更快（2.0% vs -0.6%），Ranger Energy Services, Inc.自由现金流更多（$17.1M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 1.9%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Ranger Energy Services是北美领先的陆上油田服务提供商，为上游油气运营商提供完井、修井、钻机作业及产能优化等全套解决方案，业务主要覆盖美国本土的页岩和致密资源开采作业区。
OFIX vs RNGR — 直观对比
营收规模更大
OFIX
是对方的1.5倍
$142.2M
营收增速更快
OFIX
高出2.6%
-0.6%
净利率更高
RNGR
高出3.3%
-1.0%
自由现金流更多
RNGR
多$280.0K
$16.8M
两年增速更快
OFIX
近两年复合增速
1.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $142.2M |
| 净利润 | $-2.2M | $3.2M |
| 毛利率 | 71.1% | — |
| 营业利润率 | 0.2% | 2.3% |
| 净利率 | -1.0% | 2.3% |
| 营收同比 | 2.0% | -0.6% |
| 净利润同比 | 92.4% | -44.8% |
| 每股收益（稀释后） | $-0.05 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXRNGR
| Q4 25 | $219.9M | $142.2M | ||
| Q3 25 | $205.6M | $128.9M | ||
| Q2 25 | $203.1M | $140.6M | ||
| Q1 25 | $193.6M | $135.2M | ||
| Q4 24 | $215.7M | $143.1M | ||
| Q3 24 | $196.6M | $153.0M | ||
| Q2 24 | $198.6M | $138.1M | ||
| Q1 24 | $188.6M | $136.9M |
净利润OFIXRNGR
| Q4 25 | $-2.2M | $3.2M | ||
| Q3 25 | $-22.8M | $1.2M | ||
| Q2 25 | $-14.1M | $7.3M | ||
| Q1 25 | $-53.1M | $600.0K | ||
| Q4 24 | $-29.1M | $5.8M | ||
| Q3 24 | $-27.4M | $8.7M | ||
| Q2 24 | $-33.4M | $4.7M | ||
| Q1 24 | $-36.0M | $-800.0K |
毛利率OFIXRNGR
| Q4 25 | 71.1% | — | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 68.7% | — | ||
| Q1 25 | 62.8% | — | ||
| Q4 24 | 69.0% | — | ||
| Q3 24 | 68.7% | — | ||
| Q2 24 | 67.8% | — | ||
| Q1 24 | 67.5% | — |
营业利润率OFIXRNGR
| Q4 25 | 0.2% | 2.3% | ||
| Q3 25 | -8.3% | 2.0% | ||
| Q2 25 | -7.9% | 6.1% | ||
| Q1 25 | -25.2% | 0.7% | ||
| Q4 24 | -5.3% | 6.2% | ||
| Q3 24 | -9.6% | 8.4% | ||
| Q2 24 | -12.5% | 5.3% | ||
| Q1 24 | -15.6% | -0.4% |
净利率OFIXRNGR
| Q4 25 | -1.0% | 2.3% | ||
| Q3 25 | -11.1% | 0.9% | ||
| Q2 25 | -6.9% | 5.2% | ||
| Q1 25 | -27.4% | 0.4% | ||
| Q4 24 | -13.5% | 4.1% | ||
| Q3 24 | -13.9% | 5.7% | ||
| Q2 24 | -16.8% | 3.4% | ||
| Q1 24 | -19.1% | -0.6% |
每股收益（稀释后）OFIXRNGR
| Q4 25 | $-0.05 | $0.14 | ||
| Q3 25 | $-0.57 | $0.05 | ||
| Q2 25 | $-0.36 | $0.32 | ||
| Q1 25 | $-1.35 | $0.03 | ||
| Q4 24 | $-0.76 | $0.24 | ||
| Q3 24 | $-0.71 | $0.39 | ||
| Q2 24 | $-0.88 | $0.21 | ||
| Q1 24 | $-0.95 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $10.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $450.0M | $300.1M |
| 总资产 | $850.6M | $419.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OFIXRNGR
| Q4 25 | $82.0M | $10.3M | ||
| Q3 25 | $62.9M | $45.2M | ||
| Q2 25 | $65.6M | $48.9M | ||
| Q1 25 | $58.0M | $40.3M | ||
| Q4 24 | $83.2M | $40.9M | ||
| Q3 24 | $30.1M | $14.8M | ||
| Q2 24 | $26.4M | $8.7M | ||
| Q1 24 | $27.0M | $11.1M |
总债务OFIXRNGR
| Q4 25 | — | — | ||
| Q3 25 | $157.2M | — | ||
| Q2 25 | $157.0M | — | ||
| Q1 25 | $156.9M | — | ||
| Q4 24 | $157.0M | $0 | ||
| Q3 24 | $118.5M | $0 | ||
| Q2 24 | $118.0M | $0 | ||
| Q1 24 | $118.2M | $0 |
股东权益OFIXRNGR
| Q4 25 | $450.0M | $300.1M | ||
| Q3 25 | $442.5M | $270.0M | ||
| Q2 25 | $458.3M | $276.9M | ||
| Q1 25 | $458.3M | $272.6M | ||
| Q4 24 | $503.1M | $273.8M | ||
| Q3 24 | $525.9M | $267.6M | ||
| Q2 24 | $546.0M | $260.5M | ||
| Q1 24 | $570.3M | $261.7M |
总资产OFIXRNGR
| Q4 25 | $850.6M | $419.3M | ||
| Q3 25 | $832.6M | $372.8M | ||
| Q2 25 | $837.2M | $381.7M | ||
| Q1 25 | $823.1M | $376.5M | ||
| Q4 24 | $893.3M | $381.6M | ||
| Q3 24 | $867.9M | $373.9M | ||
| Q2 24 | $882.0M | $359.6M | ||
| Q1 24 | $906.0M | $355.5M |
负债/权益比OFIXRNGR
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | 0.00× | ||
| Q3 24 | 0.23× | 0.00× | ||
| Q2 24 | 0.22× | 0.00× | ||
| Q1 24 | 0.21× | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $24.1M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $17.1M |
| 自由现金流率自由现金流/营收 | 7.6% | 12.0% |
| 资本支出强度资本支出/营收 | 4.9% | 4.9% |
| 现金转化率经营现金流/净利润 | — | 7.53× |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $42.9M |
8季度趋势，按日历期对齐
经营现金流OFIXRNGR
| Q4 25 | $27.7M | $24.1M | ||
| Q3 25 | $12.4M | $13.6M | ||
| Q2 25 | $11.6M | $20.7M | ||
| Q1 25 | $-18.4M | $10.6M | ||
| Q4 24 | $23.7M | $32.7M | ||
| Q3 24 | $11.7M | $17.7M | ||
| Q2 24 | $9.0M | $22.1M | ||
| Q1 24 | $-18.6M | $12.0M |
自由现金流OFIXRNGR
| Q4 25 | $16.8M | $17.1M | ||
| Q3 25 | $2.5M | $8.0M | ||
| Q2 25 | $4.5M | $14.4M | ||
| Q1 25 | $-25.1M | $3.4M | ||
| Q4 24 | $15.2M | $27.3M | ||
| Q3 24 | $6.3M | $10.8M | ||
| Q2 24 | $-360.0K | $6.8M | ||
| Q1 24 | $-29.1M | $5.5M |
自由现金流率OFIXRNGR
| Q4 25 | 7.6% | 12.0% | ||
| Q3 25 | 1.2% | 6.2% | ||
| Q2 25 | 2.2% | 10.2% | ||
| Q1 25 | -13.0% | 2.5% | ||
| Q4 24 | 7.0% | 19.1% | ||
| Q3 24 | 3.2% | 7.1% | ||
| Q2 24 | -0.2% | 4.9% | ||
| Q1 24 | -15.4% | 4.0% |
资本支出强度OFIXRNGR
| Q4 25 | 4.9% | 4.9% | ||
| Q3 25 | 4.8% | 4.3% | ||
| Q2 25 | 3.5% | 4.5% | ||
| Q1 25 | 3.5% | 5.3% | ||
| Q4 24 | 4.0% | 3.8% | ||
| Q3 24 | 2.7% | 4.5% | ||
| Q2 24 | 4.7% | 11.1% | ||
| Q1 24 | 5.6% | 4.7% |
现金转化率OFIXRNGR
| Q4 25 | — | 7.53× | ||
| Q3 25 | — | 11.33× | ||
| Q2 25 | — | 2.84× | ||
| Q1 25 | — | 17.67× | ||
| Q4 24 | — | 5.64× | ||
| Q3 24 | — | 2.03× | ||
| Q2 24 | — | 4.70× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
RNGR
| High Specification Rigs | $92.3M | 65% |
| Processing Solutions And Ancillary Services | $37.5M | 26% |
| Wireline Services | $12.4M | 9% |
